ExecPay

Gina Consylman

OverviewIronwood Pharmaceuticals5bluebird bio1

2021 - bluebird bio

In 2021, Gina Consylman earned a total compensation of $3.4M as Chief Financial Officer, Principal Financial Officer and Treasurer at bluebird bio.

Compensation breakdown

Bonus$75,000
Non-Equity Incentive Plan$79,208
Option Awards$2,148,167
Salary$193,846
Stock Awards$916,515
Other$738
Total$3,413,475

Consylman received $2.1M in option awards, accounting for 63% of the total pay in 2021.

Consylman also received $75K in bonus, $79.2K in non-equity incentive plan, $193.8K in salary, $916.5K in stock awards and $738 in other compensation.

Rankings

In 2021, Gina Consylman's compensation ranked 3,921st out of 12,415 executives tracked by ExecPay. In other words, Consylman earned more than 68.4% of executives.

ClassificationRankingPercentile
All
3,921
out of 12,415		68th
Division
Manufacturing
1,607
out of 5,505		71st
Major group
Chemicals And Allied Products
661
out of 2,375		72nd
Industry group
Drugs
587
out of 2,096		72nd
Industry
Biological Products, Except Diagnostic Substances
157
out of 449		65th
Source: SEC filing on May 2, 2022.
2017 - Ironwood Pharmaceuticals

Consylman's colleagues

We found six more compensation records of executives who worked with Gina Consylman at bluebird bio in 2021.

2021

Andrew Obenshain

bluebird bio

Chief Executive Officer

$9.3M

2021

Nick Leschly

bluebird bio

Chief Executive Officer

$7.3M

2021

Jason Cole

bluebird bio

Chief Business Officer

$3.5M

2021

William Baird

bluebird bio

Chief Financial Officer

$3.1M

2021

Philip Gregory

bluebird bio

Chief Scientific Officer

$3.1M

2021

Thomas Klima

bluebird bio

Chief Commercial Officer

$2.3M

News

In-depth

You may also like

Gina Consylman
bluebird bio
2021 ranking